Intravesical ALT-803 for BCG-unresponsive Bladder Cancer – A Case Report

The administration of intravesical chemotherapy or BCG often can prolong the progression-free interval after initial transurethral resection in select bladder cancer (BCa) patients. However, 60% of these patients will recur and up to 30% of patients with recurrent BCa will progress and succumb to th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Urol Case Rep
Main Authors: Huang, Jeffrey, Schisler, John, Wong, Hing C., Rosser, Charles J., Sterbis, Joseph
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2017
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5466554/
https://ncbi.nlm.nih.gov/pubmed/28607879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eucr.2017.04.015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados